Animal Health

Medical Information and Pharmacovigilance Services

Comprehensive solutions for animal heath regulatory needs

Animal Health Experience & Capabilities

Global contact center support icon

24/7/365

Fully integrated, decentralized 24/7/365 contact center.

24/7/365

Fully integrated, decentralized 24/7/365 contact center.

Read Less
Expert Witness icon

FDA, NASC, EPA, USDA, PMRA

Experience helping clients maintain compliance with regulatory agencies.

FDA, NASC, EPA, USDA, PMRA

Experience helping clients maintain compliance with regulatory agencies.

Read Less
Patient support programs icon

Highly Qualified Experts

Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Highly Qualified Experts

Our team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Read Less
Document search icon

Animal Health Expertise

Animal Health Expertise

Product compliant intake icon

Toxicology Medical Information Contact Center

Toxicology Medical Information Contact Center

Medical writing icon

Medical Writing and Content Management

Medical Writing and Content Management

Global literature review icon

Pharmacovigilance Services

Pharmacovigilance Services

ProPharma’s Animal Health Expertise

ProPharma provides comprehensive Animal Health Medical Information (MI) and Pharmacovigilance (PV) support services, including expertise with the multiple regulatory environments that varied species and active ingredients require. ProPharma service comprises a fully integrated 24/7/365 contact center to deliver current and accurate information and improve patient health and safety as well as a team of PV experts to ensure the highest levels of compliance. ProPharma’s Animal Health team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals. This enables us to respond to medical inquiries in a manner that is not only consistent with product labeling and regulatory guidance, but also recognizes the connection between animals and people and the importance of communication between interdisciplinary healthcare professionals.

With a decentralized 24/7/365 contact center, ProPharma’s team of experts provides a customized solution to fit the medical information and pharmacovigilance needs of companies of all sizes. Whether you need to augment your internal team or need to completely outsource the Animal Health MI or PV functions globally, ProPharma has the right solution for your specific needs.

Veterinarian technician holding a cat

Animal Health & Toxicology Medical Information Contact Center

We offer comprehensive support around the clock. Our global 24/7/365 contact center provides crucial services, including Adverse Event (AE) intake and follow-up, Product Complaint (PC) management, and Medical Information inquiry fulfillment with escalation protocols. Our qualified MI/TOX specialists utilize market‐leading technologies to help clients deliver current and accurate information and improve patient health and safety.

We specialize in handling accidental exposure triage with thorough toxicology assessments and follow-up. Additionally, our team is adept at crisis detection and executing client emergency bullhorn actions, ensuring rapid and effective responses to urgent situations.

Our Animal Health team includes expertise with the multiple regulatory environments that varied species and active ingredients require, ensuring the highest levels of compliance. The team includes experienced veterinarians, pharmacists, veterinary technicians, and other healthcare professionals.

Row of customer service professionals wearing headset one person smiling at camera

Animal Health Medical Writing and Content Management

Our team excels at medical writing and content management for your animal health products, leveraging our extensive expertise across various therapeutic areas and academic settings. We offer a range of services including standard document creation, custom response and content management, and response document maintenance. Additionally, our translation and localization services ensure that your critical documentation is accessible and relevant to diverse audiences.

Business worker holding espresso cup and stack of papers looking forward

Animal Health Pharmacovigilance Services

We ensure the highest standards of safety and compliance. Our services include comprehensive Adverse Drug Experience (ADE) assessment and processing, preparation and review of FDA Center for Veterinary Medicine (FDA CVM) ADE reports, and robust signal detection and management. We also offer seamless integration of regulatory services for non-FDA products, including but not limited to NASC, EPA/FIFRA, USDA, and Health Canada/PMRA, addressing all your pharmacovigilance needs.

Business professionals smiling at a desk reviewing data

Contact Us for Expert Animal Health Support 

We are dedicated to enhancing the health and well-being of animals through our comprehensive Medical Information and Pharmacovigilance services. Whether you need reliable medical information, safety monitoring, or compliance support, our team of experts is here to help.

Meet Our Animal Health Experts

  • Dane Goede Bio Photo

    Dane Goede

    Traditional Call Center Manager

    View Bio

  • Karen Gjevre Bio Photo

    Karen Gjevre

    Medical Information Supervisor, Traditional Call Center

    View Bio

Dane Goede is a veterinarian and graduate-level researcher with extensive experience in epidemiology, public health, and food safety. With extensive research experience, multiple peer-reviewed publications, and numerous formal presentations, Dane excels in translating complex clinical information for the public. He is passionate about problem-solving and collaborating with colleagues and clients.
Karen Gjevre is a veterinarian with considerable clinical experience in small animal, small ruminant, exotic pet and avian patients and is a published author in a peer-reviewed journal. She has strong attention to detail and extensive experience in medical information and pharmacovigilance protocol building, adverse event documentation, and submitting reports across a wide array of regulatory agencies.

News & Insights

Understanding For-Cause Audits: A GMP Case Study

May 11, 2026

Understanding For-Cause Audits: A GMP Case Study

Explore the critical role of for-cause audits in GMP environments, uncovering how minor discrepancies can reveal systemic risks and enhance quality oversight.qua

IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strategy

May 5, 2026

IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strat...

Preparing for an IND submission? Discover 12 critical questions sponsors should answer to reduce FDA risk, avoid delays, and strengthen submission readiness.

Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity Expectations

April 30, 2026

Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity ...

Recent cyberattacks on MedTech leaders highlight growing regulatory and patient safety risks. Explore key lessons and how FDA cybersecurity guidance is shaping compliance and resilience.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Whitepapers IND Readiness Checklist: Assess Your FDA Submission Risk

May 4, 2026

IND Readiness Diagnostic: 12 Questions Sponsors Should Answer Before Submitting

A Practical Framework to Assess IND Readiness Before Filing Identify gaps early. Reduce FDA risk. Strengthen your submission strategy. Preparing for an Investigational New Drug (IND) submission...

Case Study Reducing Patient Burden While Maintaining High-Frequency  Monitoring in a Hemophilia Gene  Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

News & Insights

Understanding For-Cause Audits: A GMP Case Study

May 11, 2026

Understanding For-Cause Audits: A GMP Case Study

Explore the critical role of for-cause audits in GMP environments, uncovering how minor discrepancies can reveal systemic risks and enhance quality oversight.qua

IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strategy

May 5, 2026

IND Readiness Isn't a Checkbox Exercise, It's a Regulatory Risk Management Strat...

Preparing for an IND submission? Discover 12 critical questions sponsors should answer to reduce FDA risk, avoid delays, and strengthen submission readiness.

Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity Expectations

April 30, 2026

Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity ...

Recent cyberattacks on MedTech leaders highlight growing regulatory and patient safety risks. Explore key lessons and how FDA cybersecurity guidance is shaping compliance and resilience.

Previous Post Arrow Next Post Arrow
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Whitepapers IND Readiness Checklist: Assess Your FDA Submission Risk

May 4, 2026

IND Readiness Diagnostic: 12 Questions Sponsors Should Answer Before Submitting

A Practical Framework to Assess IND Readiness Before Filing Identify gaps early. Reduce FDA risk. Strengthen your submission strategy. Preparing for an Investigational New Drug (IND) submission...

Case Study Reducing Patient Burden While Maintaining High-Frequency  Monitoring in a Hemophilia Gene  Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Previous Resource Arrow Next Resource Arrow
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Previous Webinar Arrow Next Webinar Arrow